Crown Aesthetics
SkinPen® Precision
FDA-cleared microneedling device
SkinPen Precision is a handheld device that a trained provider uses to perform microneedling, a procedure in which very fine, sterile needles create tiny, controlled punctures in the skin's surface, which is intended to prompt the body's own wound-healing response. It was originally developed by Bellus Medical, a Dallas, Texas company, and received FDA marketing authorization in 2018 for improving the appearance of facial acne scars in patients 22 and older. Crown Laboratories, a privately held skincare company, acquired Bellus Medical in 2018 and now markets the device through its Crown Aesthetics division. The FDA granted a second clearance in April 2021 covering the improvement of neck wrinkles, and in September 2024 Crown Aesthetics introduced an updated model, SkinPen Precision Elite, which received its own FDA clearance. Because it breaks the surface of the skin, SkinPen is regulated by the FDA as a medical device intended for use by a trained practitioner, unlike a purely topical cosmetic product.
The record
- Received FDA marketing authorization in 2018 for facial acne scars, described by the manufacturer as the first FDA clearance of a microneedling device.
- Crown Laboratories acquired Bellus Medical, SkinPen's original manufacturer, in September 2018.
- Received a second FDA clearance in April 2021 for improvement of neck wrinkles.
- SkinPen Precision Elite received FDA clearance in September 2024.
Where this came from
Also in skin treatments and skincare
SkinPen® Precision and its logo belong to Crown Aesthetics (a division of Crown Laboratories, Inc.). This page describes equipment and products used at UDERMA Medspa & Laser; it is general information, not medical advice, and whether this one suits you is a conversation to have at a consultation.
Want to know if this is right for you?
UDERMA Medspa & Laser · 36426 US Hwy 19 N, Palm Harbor, FL · 727-569-6616
Book a consultation